Effect of high-dose sodium selenite therapy on polymorphonuclear leukocyte apoptosis in non-Hodgkin's lymphoma patients

Biological Trace Element Research

Volumn 110, Issue 1, 2006, Pages 19-32

  Asfour, Inas A ^a   El Shazly, Sherin ^a   Fayek, Manal H ^a   Hegab, Hany M ^a   Raouf, Soha ^a   Moussa, Mohamed A R ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Apoptosis; Lymphoma; Neutrophils; Selenium

Indexed keywords

ANTIEMETIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; SODIUM SELENITE; VINCRISTINE SULFATE;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CELL PROTECTION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; FLOW CYTOMETRY; GASTROINTESTINAL SYMPTOM; HEART EJECTION FRACTION; HUMAN; IMMUNE DEFICIENCY; INFECTION RATE; MALE; NAUSEA AND VOMITING; NEUTROPHIL; NONHODGKIN LYMPHOMA; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELLS, CULTURED; FEMALE; HEMATOPOIESIS; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; NEUTROPHILS; SODIUM SELENITE;

EID: 33646881014     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1385/BTER:110:1:19     Document Type: Article

References (28)

1. M. C. Raff, Social controls on cell survival and cell death, Nature (London) 356, 398 (1992).
2. E. Okuma, K. Saeki, M. Simura, Y. Iscvhizaka, E. Yasugi, and A. You, Induction of apoptosis in human hemopoietic U 937 cells by granulocyte macrophage colony stimulating factor; possible existence of caspase 3 like pathway, Leukemia 14, 612-619 (2000).
3. A. Loubersheimer, A. Rickers, P. Weinmann, P. T. Daniel, M. Y. Mapara, and K. Bommert, Molecular and cellular mechanisms of apoptosis in normal and malignant B cell, Med. Oncol. Tumour Immunol. 25, 770 (1997).
4. L. M. Schwartz and B. A. Osborne, Programmed cell death, apoptosis and killer genes, Immunol. Today 14(12), 582-589 (1993).
5. D. Campane and F. L. Cleveland, Regulation of apoptosis in normal hemopoiesis and hematological disease, in Recent Advances of Hematology, M. K. Brenner and A. V. Horf brond, eds., Churchill Livingstone, New York, pp. 1-20 (1996).
6. P. G. Ekert and D. L. Vaux, Apoptosis, hemopoiesis and leukomogenesis, Bailliere's Clin. Hematol. 10, 61-76 (1997).
7. C. Prosovszky, C. Friesen, I. Herr, and K. M. Debatin, Chemotherapeutic drugs sensitize Pre-B All cells for CD95 and cytotoxic T lymphocyte mediated apoptosis, Leukemia 13, 400-409 (1999).
8. 3) therapy, Z. Gesamte Inn. Med. 46(5), 145-149 (1991).
9. R. Kasseroller, Administration of selenium in lymphedema, Med. Klin. (Munich) 92 (Suppl. 3), 50-51 (1997).
10. R. Kasseroller, Sodium selenite as prophylaxis against erysipelas in secondary lymphedema, Anticancer Res. 18(3C), 2227-2230 (1998).
11. R. G. Kasseroller and G. N. Schrauzer, Treatment of secondary lymphedema of the arm with physical decongestive therapy and sodium selenite: a review, Am. J. Ther. 7(4), 273-279 (2000).
12. J. F. Zazzo, A. Lafont, H. Darwiche, et al., Is non obstructive myocardiopathy (NOMC) in AIDS selenium deficiency related? in Selenium in Medicine and Biology, J. Neve and A. Favier, eds., Walter de Gruyter Vertag, Berlin, pp. 281-282 (1989).
13. G. N. Schrauzer, D. A. White, and C. J. Schneider, Cancer mortality correlation studies III: statistical association with dietary selenium intakes, Bioinorg. Chem. 7, 23-34 (1977).
14. I. A. Asfour, N. M. El Koaly, R. K. Kachour, and O. Fathy, Clinical utility of plasma selenium levels and glutathione peroxidase activity in the follow up of adult lymphoma patients, Egypt. J. Hematol. 21(Suppl.), 477-497 (1996).
15. R. I. Fisher, Current therapeutic paradigm for the treatment of non-Hodgkin's lymphoma. Semin Oncol. 6(Suppl 12), 2-8 (2000).
16. L. N. Harris, S. E. Jaffe, H. Stein, et al., A revised European-American classification of lymohoid neoplasms : a proposal from the International Lymphoma Study Group, Blood 84(5), 1361-1392 (1994).
17. W. Emlen, J. Niebur, and R. Kadera, Accelerated in vitro apoptosis of lymphocytes from patients with SLE, J. Immunol. 152, 3658-3691 (1994).
18. 75Se) as a tumor-localizing agent in man, J. N. Mend. 7, 197 (1966).
19. I. A. Asfour, N. Nabil, M. Hashem, et al., The impact of antioxidant therapy on apoptosis in non Hodgkin's lymphoma, Egyptian Journal of Hematology 27(Suppl. 1), 59 (2002) (abstract).
20. J. V. Vadgama, Y. Wu, D. Shen, S. Hsia, and J. Block, Effect of selenium in combination with adriamycin or taxal on sexeral different cancer cell, Anticancer Res. 20(3A), 1391-1414 (2000).
21. K. Hiraoke, S. Komiya, T. Hamada, M. Zenmyo, and A. Inoue, Osteosarcoma cell apoptosis induced by selenium, J. Orthop. Res. 19(5), 809-814 (2001).
22. J. Mai, P. S. Sorensen, and J. C. Hansen, High dose anti oxidant supplementation to MS patients. Effect on glutathione peroxidase clinical safety and absorption of selenium, Biol. Trace Element Res. 24(2), 109-117 (1990).
23. A. C. Wilson, H. J. Thompson, P. G. Schedin, N. W. Gibson, H. E. Ganther, Effect of methylated form of selenium on cell viability and the cadathai of DNA strand break-age, Bichem. Pharmacol. 143, 1137-1141 (1992).
24. D. G. Menter, A. L. Sabichi, and S. M. Lippman, Selenium effect of prostate cell growth, Cancer Epidemiol. Biomarker Prev. 9(11), 1171-1182 (2000).
25. C. Reedman, A. S. Julie, T. B. Antonio, et al., Inhibitory effect of slenomethionine on the growth of 3 selected human tumor cell lines, Cancer Lett. 25, 103-110 (1998).
26. Guo, A. N. Xue, S. Q. Wang, J. Y. Chen, Y. D. Wu, and B. Zhang, Induction of apoptosis by superoxide anion and the protective effect of selenium and vitamin E, Biomed. Environ. Sci. 14(3), 241-247 (2001).
27. S. O. Yoon, M. M. Kirn, S. J. D. Park, J. K. Chung, and A. S. Chung, Selenite suppresses hydrogen peroxid induced cell apoptosis through inhibition of ASK1/JNK and activation of P13-K/AKT pathways, FASEB J. 16(1), 111-113 (2002).
28. K. M. Brown, K. Pickard, F. Nicolf, G. J. Beckett, G. G. Duthie, and J. R. Arther, Effect of organic and inorganic selenium supplementation on selenoenzyme activity in blood lymphocytes, granulocytes platelets and erythrocytes, Clinical Science (London) 98(5), 593-599 (2000).